Table 2.
Age, mean (SD, range), years | ||
All patients | 41 (10, 20–58) | |
Sex, n (%) | ||
Female | 43 (98) | |
Male | 1 (2) | |
Ethnicity, n (%) | ||
White | 32 (73) | |
African American | 10 (23) | |
Asia | 2 (4) | |
Diagnosis, n (%) | Patient | Lesion |
Solitary adenoma | 9 (20) | 9 (6) |
Multiple adenomas | 18 (41) | 52 (37) |
Adenomatosis | 17 (39) | 81 (57) |
Total number | 44 | 142 |
Size | Patient (lesion) | Follow-up, mean (range), months |
<3 cm | 28 (80) | 46 (1–139) |
3–5 cm | 17 (34) | 40 (1–108) |
≥5 cm | 18 (28) | 40 (1–108) |
History of OCPs/hormone | Patient (lesion) | |
Taking and discontinuation | 35 (122) | |
Taking without termination | 1 (5) | |
NA | 8 (15) |
SD, standard deviation; OCP, oral contraceptive pills; NA, not applicable.